{
    "id": 25313,
    "fullName": "CRLF2 rearrange",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CRLF2 rearrange indicates an unspecified rearrangement of the CRLF2 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 64109,
        "geneSymbol": "CRLF2",
        "terms": [
            "CRLF2",
            "CRL2",
            "CRLF2Y",
            "TSLPR"
        ]
    },
    "variant": "rearrange",
    "createDate": "09/07/2016",
    "updateDate": "09/07/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8220,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cell line xenograft models of acute lymphobastic leukemia with a CRLF2 rearrangement demonstrated sensitivity to treatment with Rapamune (sirolimus), resulting in decreased cell burden and inhibition of S6 and the PI3K/mTOR pathway (J Clin Oncol 30, 2012 (suppl; abstr 9506)).",
            "molecularProfile": {
                "id": 26199,
                "profileName": "CRLF2 rearrange"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 9952,
                "name": "acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6574,
                    "pubMedId": null,
                    "title": "In vivo monitoring of JAK/STAT and PI3K/mTOR signal transduction inhibition in pediatric CRLF2-rearranged acute lymphoblastic leukemia (ALL)",
                    "url": "http://meetinglibrary.asco.org/content/98540-114"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26199,
            "profileName": "CRLF2 rearrange",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}